Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Hangzhou Tian-Mu-Shan Pharm. Enterp. Co    600671   CNE000000BF3

HANGZHOU TIAN-MU-SHAN PHARM. ENTERP. CO

(600671)
End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 06/17
12.23 CNY   +2.51%
 SummaryQuotesChartsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/11/2019 06/12/2019 06/13/2019 06/14/2019 06/17/2019 Date
12.27(c) 12.18(c) 12.37(c) 11.93(c) 12.23 Last
3 281 647 2 854 820 2 508 284 2 658 620 2 597 816 Volume
+1.40% -0.73% +1.56% -3.56% +2.51% Change
More quotes
Company
Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd is a China based company principally engaged in the research and development, production and sales of pharmaceuticals and related health products. The Company is mainly engaged in the manufacture of chemical drug substances, processing of... 
Sector
Pharmaceuticals
Calendar
06/19 | 02:30amShareholder meeting
More about the company
Latest news on HANGZHOU TIAN-MU-SHAN PHAR

- No features available -

More news
Sector news : Pharmaceuticals - NEC
08:54aPFIZER : to Buy Array BioPharma in $10.64 Billion Deal -- 2nd Update
DJ
08:35aVoyager Therapeutics Restructures Gene Therapy Relationship with Sanofi Genzy..
DJ
08:11aPFIZER : to Buy Array BioPharma in $10.64 Billion Deal -- Update
DJ
08:09aARRAY BIOPHARMA : Pfizer bolsters cancer portfolio with $10.64 billion deal for ..
RE
07:59aBeiGene Says Agrees to End Collaboration With Celgene
DJ
More sector news : Pharmaceuticals - NEC
Chart HANGZHOU TIAN-MU-SHAN PHARM. ENTERP. CO
Duration : Period :
Hangzhou Tian-Mu-Shan Pharm. Enterp. Co Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HANGZHOU TIAN-MU-SHAN PHAR
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Managers
NameTitle
Zu Yue Li General Manager & Board Secretary
Rui Yong Zhao Chairman
Ya Min Zhou Chief Financial Officer
Ling Zhang Independent Director
Zhi Qiang Qu Director
Sector and Competitors
1st jan.Capitalization (M$)
HANGZHOU TIAN-MU-SHAN PHARM. ENTERP. CO-25.44%217
JOHNSON & JOHNSON8.55%348 981
PFIZER-2.04%233 072
ROCHE HOLDING LTD.13.39%227 848
NOVARTIS20.35%220 893
MERCK AND COMPANY8.34%206 641